These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2934730)

  • 1. [Should ticlopidine be forbidden for hemodialysis patients waiting for renal transplantation?].
    Spiesser R; Lavenet F; Enon B; Jacob JP; Chapillon M; Riberi P
    Presse Med; 1985 Dec; 14(43):2197-8. PubMed ID: 2934730
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does the use of ticlopidine in hemodialyzed patients contraindicate renal transplantation?].
    Louis J; Renoult E; Hurault De Ligny B; Vagner JC; Kessler M
    Presse Med; 1986 Feb; 15(8):399. PubMed ID: 2938165
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of ticlopidine in chronic hemodialyzed patients. Counter-indication in future renal transplant receivers].
    Lang P; Plaisant B; Benoit G; Brasseur L; Charpentier B; Fries D
    Presse Med; 1985 Apr; 14(16):894-5. PubMed ID: 3158926
    [No Abstract]   [Full Text] [Related]  

  • 4. [Per- and postoperative hemorrhage during ticlopidine therapy].
    Hurault de Ligny B; Trechot P; Kessler M; Vagner JC
    Cah Anesthesiol; 1985; 33(3):257. PubMed ID: 3893646
    [No Abstract]   [Full Text] [Related]  

  • 5. Leukopenia due to ticlopidine in a patient with chronic renal failure.
    Bedani PL; Fiocchi O; Scapoli PL; Farinelli A
    Haematologica; 1984; 69(5):641-2. PubMed ID: 6437940
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of ticlopidine and heparin on hemodialysis in dogs.
    Gross ML; Bush H; Weinger R; Hamburger RJ; Flamenbaum W
    J Lab Clin Med; 1982 Dec; 100(6):887-95. PubMed ID: 7142790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticlopidine: quo vadis? Adverse reactions in man.
    Goyan JE
    Agents Actions Suppl; 1984; 15():116-25. PubMed ID: 6592942
    [No Abstract]   [Full Text] [Related]  

  • 8. [Agranulocytosis caused by ticlopidine].
    Marmont AM; Lotti G; Nati S; Martinengo M; Morgano A
    Recenti Prog Med; 1985 May; 76(5):245-8. PubMed ID: 4023387
    [No Abstract]   [Full Text] [Related]  

  • 9. Overview: clinical experiences with ticlopidine.
    Day HJ
    Agents Actions Suppl; 1984; 15():297-309. PubMed ID: 6385654
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thrombocytopenia due to antibodies induced by ticlopidine].
    Claas FH; de Fraiture WH; Meyboom RH
    Nouv Rev Fr Hematol (1978); 1984; 26(5):323-4. PubMed ID: 6504695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticlopidine can cause chronic diarrhoea.
    Giardina MG; Matarazzo M; Cacciatore L; De Marco F
    Lancet; 1984 Feb; 1(8373):407. PubMed ID: 6141477
    [No Abstract]   [Full Text] [Related]  

  • 12. Ticlopidine: quo vadis? Subarachnoid hemorrhage.
    Ono H; Mizukami M; Kitamura K; Kikuchi H
    Agents Actions Suppl; 1984; 15():259-72. PubMed ID: 6385650
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholestatic fatty liver of probably iatrogenic origin].
    Pistone AM; Podestà F; Raviolo E; Testa D; Grosso B; Toselli P; Nyffeneger G
    Recenti Prog Med; 1986 Apr; 77(4):188-90. PubMed ID: 3715186
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bone marrow culture in patients treated with Ticlopidine].
    Resegotti L; Pistone MA; Testa D; Charbonnier R; Toselli P; Vivalda S
    Nouv Rev Fr Hematol (1978); 1985; 27(1):19-22. PubMed ID: 4039435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications.
    Panak E; Maffrand JP; Picard-Fraire C; Vallée E; Blanchard J; Roncucci R
    Haemostasis; 1983; 13 Suppl 1():1-54. PubMed ID: 6642292
    [No Abstract]   [Full Text] [Related]  

  • 16. Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis--a multicenter collaborative double blind study.
    Kobayashi K; Maeda K; Koshikawa S; Kawaguchi Y; Shimizu N; Naito C
    Thromb Res; 1980 Oct; 20(2):255-61. PubMed ID: 7209880
    [No Abstract]   [Full Text] [Related]  

  • 17. Spinal subarachnoid hematoma after lumbar puncture in a patient receiving antiplatelet therapy.
    Mayumi T; Dohi S
    Anesth Analg; 1983 Aug; 62(8):777-9. PubMed ID: 6869865
    [No Abstract]   [Full Text] [Related]  

  • 18. Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
    Chan KE; Edelman ER; Wenger JB; Thadhani RI; Maddux FW
    Circulation; 2015 Mar; 131(11):972-9. PubMed ID: 25595139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the antithrombotic efficacy of ticlopidine in man.
    Panak E; Blanchard J; Roe RL
    Agents Actions Suppl; 1984; 15():148-66. PubMed ID: 6385644
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of a new platelet aggregation inhibitor, ticlopidine, in hemodialysis].
    Griffanti-Bartoli F; Altomonte F; Pitton L; Armani U; Piana A
    Arch Maragliano Patol Clin; 1979; 35(2):73-80. PubMed ID: 263724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.